BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 30541857)

  • 21. Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D Virus In Vivo.
    He W; Cao Z; Mao F; Ren B; Li Y; Li D; Li H; Peng B; Yan H; Qi Y; Sun Y; Wang F; Sui J; Li W
    J Virol; 2016 Oct; 90(19):8866-74. PubMed ID: 27466423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.
    Yan H; Zhong G; Xu G; He W; Jing Z; Gao Z; Huang Y; Qi Y; Peng B; Wang H; Fu L; Song M; Chen P; Gao W; Ren B; Sun Y; Cai T; Feng X; Sui J; Li W
    Elife; 2012 Nov; 3():. PubMed ID: 25409679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infection.
    Ueda Y; Gu W; Dansako H; Nishitsuji H; Satoh S; Shimotohno K; Kato N
    Biochem Biophys Res Commun; 2019 Jul; 515(1):156-162. PubMed ID: 31133379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.
    Iwamoto M; Watashi K; Tsukuda S; Aly HH; Fukasawa M; Fujimoto A; Suzuki R; Aizaki H; Ito T; Koiwai O; Kusuhara H; Wakita T
    Biochem Biophys Res Commun; 2014 Jan; 443(3):808-13. PubMed ID: 24342612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
    Qiao L; Sui J; Luo G
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly diversified shrew hepatitis B viruses corroborate ancient origins and divergent infection patterns of mammalian hepadnaviruses.
    Rasche A; Lehmann F; König A; Goldmann N; Corman VM; Moreira-Soto A; Geipel A; van Riel D; Vakulenko YA; Sander AL; Niekamp H; Kepper R; Schlegel M; Akoua-Koffi C; Souza BFCD; Sahr F; Olayemi A; Schulze V; Petraityte-Burneikiene R; Kazaks A; Lowjaga KAAT; Geyer J; Kuiken T; Drosten C; Lukashev AN; Fichet-Calvet E; Ulrich RG; Glebe D; Drexler JF
    Proc Natl Acad Sci U S A; 2019 Aug; 116(34):17007-17012. PubMed ID: 31371507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular uptake of hepatitis B virus envelope L particles is independent of sodium taurocholate cotransporting polypeptide, but dependent on heparan sulfate proteoglycan.
    Somiya M; Liu Q; Yoshimoto N; Iijima M; Tatematsu K; Nakai T; Okajima T; Kuroki K; Ueda K; Kuroda S
    Virology; 2016 Oct; 497():23-32. PubMed ID: 27420796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.
    Nkongolo S; Ni Y; Lempp FA; Kaufman C; Lindner T; Esser-Nobis K; Lohmann V; Mier W; Mehrle S; Urban S
    J Hepatol; 2014 Apr; 60(4):723-31. PubMed ID: 24295872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HBV life cycle is restricted in mouse hepatocytes expressing human NTCP.
    Li H; Zhuang Q; Wang Y; Zhang T; Zhao J; Zhang Y; Zhang J; Lin Y; Yuan Q; Xia N; Han J
    Cell Mol Immunol; 2014 Mar; 11(2):175-83. PubMed ID: 24509445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide.
    Kaneko M; Futamura Y; Tsukuda S; Kondoh Y; Sekine T; Hirano H; Fukano K; Ohashi H; Saso W; Morishita R; Matsunaga S; Kawai F; Ryo A; Park SY; Suzuki R; Aizaki H; Ohtani N; Sureau C; Wakita T; Osada H; Watashi K
    Sci Rep; 2018 Feb; 8(1):2769. PubMed ID: 29426822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes.
    König A; Döring B; Mohr C; Geipel A; Geyer J; Glebe D
    J Hepatol; 2014 Oct; 61(4):867-75. PubMed ID: 24845614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of HBV transcription by sodium taurocholate cotransporting polypeptide at the postentry step is inhibited by the entry inhibitor Myrcludex B.
    Zhao K; Liu S; Chen Y; Yao Y; Zhou M; Yuan Y; Wang Y; Pei R; Chen J; Hu X; Zhou Y; Zhao H; Lu M; Wu C; Chen X
    Emerg Microbes Infect; 2018 Nov; 7(1):186. PubMed ID: 30459339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of S267F variant of NTCP on the patients with chronic hepatitis B.
    Lee HW; Park HJ; Jin B; Dezhbord M; Kim DY; Han KH; Ryu WS; Kim S; Ahn SH
    Sci Rep; 2017 Dec; 7(1):17634. PubMed ID: 29247233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus-targeting sodium taurocholate cotransporting polypeptide mediates HBV infection and damage in human renal podocytes.
    Wang L; Wang C; Wang X; Cao Y; Guo X; Ye Z
    Microbiol Spectr; 2024 Mar; 12(3):e0136523. PubMed ID: 38315030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization.
    Iwamoto M; Saso W; Sugiyama R; Ishii K; Ohki M; Nagamori S; Suzuki R; Aizaki H; Ryo A; Yun JH; Park SY; Ohtani N; Muramatsu M; Iwami S; Tanaka Y; Sureau C; Wakita T; Watashi K
    Proc Natl Acad Sci U S A; 2019 Apr; 116(17):8487-8492. PubMed ID: 30952782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection.
    Takemori T; Sugimoto-Ishige A; Nishitsuji H; Futamura Y; Harada M; Kimura-Someya T; Matsumoto T; Honma T; Tanaka M; Yaguchi M; Isono K; Koseki H; Osada H; Miki D; Saito T; Tanaka T; Fukami T; Goto T; Shirouzu M; Shimotohno K; Chayama K
    J Virol; 2022 Mar; 96(5):e0168621. PubMed ID: 34985994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentration of Na
    Oswald A; Chakraborty A; Ni Y; Wettengel JM; Urban S; Protzer U
    Sci Rep; 2021 Oct; 11(1):19799. PubMed ID: 34611272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel evidence indicates the presence and replication of hepatitis B virus in breast cancer tissue.
    Qin B; Zhao K; Wei J; Wang X; Xu M; Lang J; Sun H; Jin K
    Oncol Rep; 2020 Jan; 43(1):296-305. PubMed ID: 31746395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Live Cell Imaging Confocal Microscopy Analysis of HBV Myr-PreS1 Peptide Binding and Uptake in NTCP-GFP Expressing HepG2 Cells.
    König A; Glebe D
    Methods Mol Biol; 2017; 1540():27-36. PubMed ID: 27975305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver.
    Nakabori T; Hikita H; Murai K; Nozaki Y; Kai Y; Makino Y; Saito Y; Tanaka S; Wada H; Eguchi H; Takahashi T; Suemizu H; Sakamori R; Hiramatsu N; Tatsumi T; Takehara T
    Sci Rep; 2016 Jun; 6():27782. PubMed ID: 27278060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.